Figure 6From: Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis Cross-protection against persistent infection of ≥ 6-months with HPV 31, 33, 45, 52 and 58 Back to article page